Jay Watkins

Lecturer in Management at Stanford Graduate School of Business

Schools

  • Stanford Graduate School of Business

Expertise

Links

Biography

Stanford Graduate School of Business

Bio

Jay Watkins is a Managing Director at De Novo Ventures. Mr. Watkins is an operating executive with extensive experience founding and funding healthcare companies. Prior to joining DeNovo in 2002, Mr. Watkins was a co-founder and founding CEO of Origin Medsystems, a venture funded medical technology start-up which was purchased by Eli Lilly & Company. After Lilly formed Guidant, he joined the Management Committee and served as president of several divisions, including the Minimally Invasive Surgery Group, and Heart Rhythm Technologies. While President of the Cardiac and Vascular Surgery Group he initiated the development of a minimally invasive vein harvesting technology. He co-founded Gynecare, a women’s health care company which was spun out, taken public, and subsequently acquired by Johnson & Johnson. He was also the founding President of Compass, Guidant’s corporate business development and new ventures group where he was directly involved in the acquisition of two public companies and led venture investments in 14 companies including Impella, which developed the world’s first catheter delivered microaxial heart pump and Intuitive Surgical which developed the world’s largest selling surgical robot. Prior to founding Origin, Mr. Watkins held management positions in several start-ups, including Microgenics Corporation (acquired by Boehringer Mannheim), and was a consultant with McKinsey & Company. He has served as a board member for both private and public medtech companies and has been an active advisor and faculty member for the Kauffman Labs program which is dedicated to educating and training founders. Mr. Watkins received his MBA from Harvard Business School and his undergraduate degree from Stanford University.

Teaching

Degree Courses

2017-18

OIT 384: Biodesign Innovation: Needs Finding and Concept Creation

In this two-quarter course series (OIT 384/5), multidisciplinary student teams from medicine, business, and engineering work together to identify real-world unmet healthcare needs, invent new health technologies to address them, and plan for...

OIT 385: Biodesign Innovation: Concept Development and Implementation

In this two-quarter course series (OIT 384/5), multidisciplinary student teams from medicine, business, and engineering work together to identify real-world unmet healthcare needs, invent new health technologies to address them, and plan for...

2016-17

OIT 384: Biodesign Innovation: Needs Finding and Concept Creation

In this two-quarter course series (OIT 384/5), multidisciplinary student teams identify real-world unmet healthcare needs, invent new medtech products to address them, and plan for their development into patient care. During the first quarter (...

OIT 385: Biodesign Innovation: Concept Development and Implementation

In this two-quarter course series ( OIT 384/5), multidisciplinary student teams identify real-world unmet healthcare needs, invent new medtech products to address them, and plan for their development into patient care. During the first quarter (...

Read about executive education

Other experts

Jeff Anapolsky

Jeff Anapolsky is a restructuring professional with over 15 years of achieving successful results as an advisor and investor for special situations involving bankruptcies and out-of-court workouts. His investing experience involves sub-par debt, DIP loans, credit default swaps, trade claims, reor...

Don Kleinmuntz

Dr. Don Kleinmuntz is an expert on decision and risk analysis and business analytics, with significant contributions to both academia and industry. He is currently Principal at Kleinmuntz Associates, an analytics consultancy, and Adjunct Professor of IT, Analytics, and Operations at the Universit...

Looking for an expert?

Contact us and we'll find the best option for you.

Something went wrong. We're trying to fix this error.